Globus Medical, Inc. GMED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 141.17M | 151.57M | 124.30M | 140.59M | 118.97M |
| Total Depreciation and Amortization | 70.20M | 69.58M | 69.95M | 68.82M | 70.96M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.45M | 43.65M | 36.23M | 60.68M | 58.03M |
| Change in Net Operating Assets | 23.41M | -55.07M | -28.12M | -21.51M | 1.74M |
| Cash from Operations | 265.23M | 209.74M | 202.36M | 248.59M | 249.70M |
| Capital Expenditure | -40.39M | -33.17M | -39.62M | -46.20M | -35.82M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -16.01M | -1.50M | -4.91M | 0.00 | -4.67M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.51M | -94.38M | -138.15M | -65.25M | -35.36M |
| Cash from Investing | -155.90M | -129.05M | -182.67M | -111.45M | -75.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 15.88M | 10.97M | 25.96M | 62.76M | 11.08M |
| Repurchase of Common Stock | -142.94M | -136.07M | -3.44M | -45.21M | -39.75M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.70M | -9.40M | -4.32M | -4.33M | -3.38M |
| Cash from Financing | -130.76M | -134.50M | 18.20M | 13.22M | -32.04M |
| Foreign Exchange rate Adjustments | 1.38M | 598.00K | -3.09M | 4.03M | 512.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.06M | -53.21M | 34.79M | 154.39M | 142.32M |